HCRT and neoplasm: To validate our hypothesis in vivo, we determined tumor deposition of OX/GA in MC38 tumor-bearing C57BL/6 mice with cytokine blocking antibodies and in MC38 tumor-bearing TekΔSTING mice (EC-specific STING conditional knockout mice).